Transforming growth factor beta 1 signaling axis (TGF-β1 signaling axis)

The Transforming growth factor beta 1 (TGF-beta 1) signaling axis is a critical pathway involved in regulating a wide array of cellular processes, including cell growth, differentiation, apoptosis, and the synthesis of the extracellular matrix (Massagué, 2012). Signaling is initiated when the TGF-beta 1 ligand binds to a heteromeric receptor complex consisting of TGF-beta receptor type II (TGFBR2) and type I (TGFBR1/ALK5), leading to the phosphorylation of Smad2 and Smad3 proteins. These Smads then form a complex with Smad4 and translocate to the nucleus to regulate gene expression. In the context of disease, the TGF-beta 1 axis plays a dual role in oncology, acting as a tumor suppressor in early-stage cancers but promoting epithelial-mesenchymal transition (EMT), metastasis, and immune evasion in advanced stages (Akhurst & Hata, 2012). Furthermore, it is a primary driver of pathological fibrosis in organs such as the lungs, liver, and kidneys. Therapeutic strategies targeting this axis include monoclonal antibodies that neutralize the ligand, small molecule inhibitors of the receptor's kinase activity, and 'traps' that sequester the cytokine to prevent receptor activation (Teicher, 2021). Clinical development has faced challenges due to the pleiotropic nature of the pathway, necessitating careful patient selection and monitoring for off-target effects like cardiotoxicity.

Other names

TGF-beta 1 pathwayTGFB1 signalingTGF-beta/Smad signaling pathwayTGF-beta 1/Smad2/3 axis

Inhibition of TGF-beta ligand binding to receptors, inhibition of TGF-beta receptor type I (ALK5) kinase activity, or sequestration of TGF-beta ligands using trap proteins (Akhurst & Hata, 2012).